+152.4%
MRNA vs GH
+523.2%
-370.8%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | +0.3% | +1.0% | +1.2% |
| 7D | -13.8% | -6.0% | -7.9% | -12.2% |
| 30D | -17.7% | -10.5% | -7.2% | -14.9% |
| 3M | +14.3% | -10.9% | +25.2% | +18.3% |
| 6M | +336.0% | +48.3% | +287.7% | +299.6% |
| YTD | +575.9% | +42.5% | +533.4% | +520.8% |
| 1Y | +724.4% | +46.2% | +678.1% | +651.2% |
| All | +152.4% | +523.2% | -370.8% | +78.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GH.
Daily Out/Under-Performance
Portfolio return minus GH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling